Q4 2024 |
16 |
$12.3M |
+$10.4M |
-$4.95M |
+$5.42M |
EOSE, SPY, IWM, VANI, BTBT
|
13F-HR |
2/14/2025, 07:55 AM |
Q3 2024 |
27 |
$7.22M |
+$4.45M |
-$4.38M |
+$65.5K |
VANI, VLCN, HCWC, IMNN, CORZ
|
13F-HR |
11/14/2024, 08:11 AM |
Q2 2024 |
27 |
$7.53M |
+$2.77M |
-$7.17M |
-$4.41M |
VANI, CORZW, RDHL, GWAV, ELTK
|
13F-HR |
8/14/2024, 07:08 AM |
Q1 2024 |
41 |
$14.8M |
+$12.8M |
-$7.71M |
+$5.04M |
VANI, ELTK, RDHL, TNXP, GMM
|
13F-HR |
5/15/2024, 07:51 AM |
Q4 2023 |
42 |
$10.7M |
+$7.37M |
-$25.4M |
-$18.1M |
TNXP, BCAN, MMAT, PHUN, RCON
|
13F-HR |
2/14/2024, 06:44 AM |
Q3 2023 |
114 |
$136M |
+$42.6M |
-$45.1M |
-$2.5M |
IWM, SPY, SEEL, TC, RCON
|
13F-HR |
11/14/2023, 07:25 AM |
Q2 2023 |
122 |
$121M |
+$45.8M |
-$43M |
+$2.87M |
BIOR, SONNXXXX, AKTX, SIDU, RCON
|
13F-HR |
8/14/2023, 06:17 PM |
Q1 2023 |
89 |
$115M |
+$27.8M |
-$3.91M |
+$23.9M |
NMTRQ, AKTX, TC, DOGZ, RCON
|
13F-HR |
5/15/2023, 09:09 AM |
Q4 2022 |
109 |
$114M |
+$42.1M |
-$30.9M |
+$11.2M |
NVCT, TBLT, DOGZ, TC, IWM
|
13F-HR |
2/14/2023, 07:40 AM |
Q3 2022 |
113 |
$78.6M |
+$34M |
-$22.9M |
+$11.1M |
BGXX, NVCT, DOGZ, BLRX, AKTX
|
13F-HR |
11/14/2022, 08:28 AM |
Q2 2022 |
126 |
$146M |
+$58M |
-$57.4M |
+$571K |
GEVO, DOGZ, MMAT, COCP, PMCB
|
13F-HR |
8/15/2022, 08:16 AM |
Q1 2022 |
144 |
$651M |
+$283M |
-$39.6M |
+$244M |
COCP, PMCB, BIVI, NISN, CNTX
|
13F-HR |
5/16/2022, 08:34 AM |
Q4 2021 |
184 |
$662M |
+$184M |
-$54.1M |
+$130M |
BTBT, NISN, SRNEQ, ESPR, SWAG
|
13F-HR |
2/14/2022, 06:54 AM |
Q3 2021 |
94 |
$456M |
+$111M |
-$54.8M |
+$56.2M |
BTBT, BTCM, SRNE, VXXXXXX, COCP
|
13F-HR |
11/15/2021, 08:25 AM |
Q2 2021 |
85 |
$462M |
+$389M |
-$46.5M |
+$342M |
SRNE, COCP, RENB, ATOS, ATER
|
13F-HR |
8/16/2021, 09:14 AM |
Q1 2021 |
82 |
$136M |
+$124M |
-$88.2M |
+$36.3M |
SRNE, EYES, ASXC, NBEVQ, WIMI
|
13F-HR |
5/14/2021, 05:44 PM |
Q4 2020 |
105 |
$518M |
+$119M |
-$73.9M |
+$45.3M |
BIIB, AZN, MRNA, XWEL, CVM
|
13F-HR |
2/16/2021, 08:00 AM |
Q3 2020 |
127 |
$665M |
+$274M |
-$64.4M |
+$209M |
BIIB, MRNA, AZN, SRNEQ, IMMU
|
13F-HR |
11/16/2020, 08:09 AM |
Q2 2020 |
101 |
$496M |
+$297M |
-$82.3M |
+$214M |
BIIB, XLV, MRNA, XERS, PLLXXXX
|
13F-HR |
8/14/2020, 08:48 AM |
Q1 2020 |
89 |
$241M |
+$139M |
-$161M |
-$21.9M |
XLV, GLD, NOVNXXXX, ENLV, OTLK
|
13F-HR |
5/15/2020, 05:00 PM |
Q4 2019 |
65 |
$359M |
+$229M |
-$33.3M |
+$196M |
GLD, ONTX, ODTC, GNCA, BPTH
|
13F-HR |
2/14/2020, 03:11 PM |
Q3 2019 |
90 |
$183M |
+$78.7M |
-$23.8M |
+$54.9M |
TEUM, ODTC, ATNM, CRMD, GNCA
|
13F-HR |
11/14/2019, 05:17 PM |
Q2 2019 |
81 |
$73.1M |
+$33.6M |
-$58.3M |
-$24.6M |
ODTC, AMPE, GNCA, INNT, SHIPW
|
13F-HR |
8/14/2019, 04:04 PM |
Q1 2019 |
78 |
$207M |
+$117M |
-$177M |
-$60.8M |
ODTC, BCLI, ORMP, LOOP, SOLO
|
13F-HR |
5/15/2019, 05:10 PM |
Q4 2018 |
115 |
$437M |
+$146M |
-$78.1M |
+$68.4M |
BIIB, ESPR, XBI, BCLI, XERS
|
13F-HR |
2/13/2019, 04:56 PM |
Q3 2018 |
117 |
$766M |
+$265M |
-$121M |
+$144M |
NKTR, BIIB, ODTC, XERS, UMRX
|
13F-HR |
11/13/2018, 05:14 PM |
Q2 2018 |
138 |
$647M |
+$264M |
-$330M |
-$66.6M |
BIIB, NVO, ODTC, NKTR, XERS
|
13F-HR |
8/14/2018, 08:48 AM |
Q1 2018 |
151 |
$840M |
+$569M |
-$538M |
+$30.7M |
BIIB, ODTC, SPY, UMRX, INCY
|
Restatement |
5/15/2018, 03:35 PM |
Q4 2017 |
159 |
$1.1B |
+$363M |
-$449M |
-$85.6M |
BMY, ODTC, ESPR, ONCE, MNKD
|
Restatement |
2/15/2018, 01:15 PM |
Q3 2017 |
161 |
$1.53B |
+$372M |
-$249M |
+$123M |
BMY, AXGTXXXX, ESPR, ONS, GWPH
|
13F-HR |
11/14/2017, 08:32 AM |
Q2 2017 |
212 |
$1.39B |
+$340M |
-$358M |
-$18.3M |
TSRO, UTHR, SGENXXXX, BIOAQ, SPNC
|
Restatement |
9/27/2017, 11:49 AM |
Q1 2017 |
253 |
$1.85B |
+$1.07B |
-$284M |
+$785M |
BMY, AMGN, ONS, IONS, MTFB
|
Restatement |
5/16/2017, 10:09 AM |
Q4 2016 |
287 |
$1.72B |
+$555M |
-$650M |
-$94.8M |
REGN, SRPT, AMGN, BMY, LLY
|
13F-HR |
2/13/2017, 05:55 PM |
Q3 2016 |
302 |
$2.66B |
+$1.3B |
-$436M |
+$867M |
SRPT, REGN, AMGN, ONS, BMY
|
13F-HR |
11/14/2016, 08:37 AM |
Q2 2016 |
278 |
$1.91B |
+$861M |
-$319M |
+$542M |
REGN, AMGN, SRPT, ABT, ONS
|
13F-HR |
8/15/2016, 10:06 AM |
Q1 2016 |
288 |
$1.98B |
+$940M |
-$171M |
+$769M |
IMMU, SPY, AMGN, REGN, SRPT
|
13F-HR |
5/13/2016, 04:54 PM |
Q4 2015 |
305 |
$1.81B |
+$323M |
-$611M |
-$289M |
IWM, GWPH, ALKS, VPCOU, TENX
|
13F-HR |
2/16/2016, 08:37 AM |
Q3 2015 |
375 |
$2.4B |
+$900M |
-$303M |
+$597M |
IWM, BIIB, BMRN, MYL, PXD
|
13F-HR |
11/16/2015, 09:06 AM |
Q2 2015 |
312 |
$2.71B |
+$1.1B |
-$472M |
+$627M |
TLT, MRK, GBSNU, XOM, PXD
|
13F-HR |
8/14/2015, 11:17 AM |
Q1 2015 |
278 |
$2.39B |
+$1.36B |
-$499M |
+$864M |
B108PS, IWM, ZGNXXXXX, MBBYF, IOC
|
13F-HR |
5/15/2015, 09:25 AM |
Q4 2014 |
230 |
$2.03B |
+$783M |
-$526M |
+$257M |
PFE, ACAD, B108PS, AZN, IOC
|
13F-HR |
2/17/2015, 05:19 AM |
Q3 2014 |
248 |
$1.95B |
+$805M |
-$359M |
+$446M |
B108PS, IOC, TENX, GEVA, TSLA
|
Restatement |
11/18/2014, 03:03 PM |
Q2 2014 |
249 |
$2.32B |
+$782M |
-$448M |
+$333M |
WY, TEVA, REGN, ACAD, OXBT
|
13F-HR |
8/14/2014, 09:58 AM |
Q1 2014 |
230 |
$1.78B |
+$1.04B |
-$259M |
+$779M |
SPY, TEVA, OXBT, ACAD, GILD
|
13F-HR |
5/13/2014, 05:47 PM |
Q4 2013 |
214 |
$1.57B |
|
|
|
MNKDXXXX, TEVA, BAX, ACAD, SRPT
|
13F-HR |
2/13/2014, 06:03 PM |